Dose-Escalating Study to Evaluate MEDI-534 in Healthy Adults

Trial Profile

Dose-Escalating Study to Evaluate MEDI-534 in Healthy Adults

Completed
Phase of Trial: Phase I

Latest Information Update: 02 Jul 2007

At a glance

  • Drugs MEDI 534 (Primary)
  • Indications Parainfluenza virus infections; Respiratory syncytial virus infections
  • Focus Adverse reactions
  • Most Recent Events

    • 02 Jul 2007 Status changed from recruiting to completed
    • 19 Oct 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top